Navigation Links
DiagnoCure announces fourth quarter and full year 2008 earnings conference call and webcast
Date:12/5/2008

s test is also available through laboratories in the U.S. using PCA3 analyte specific reagents (ASR) from Gen-Probe, in Europe as the CE-marked PROGENSA(TM) PCA3 in vitro assay, and in Canada. In addition to its own research, the Company intends to acquire or in-license additional promising cancer biomarkers from both academic and commercial institutions. For more information, visit www.diagnocure.com.

Forward-looking statements

This release contains forward-looking statements that involve known and unknown risks, uncertainties and assumptions that may cause actual results to differ materially from those expected. By their very nature, forward-looking statements are based on expectations and hypotheses and also involve risks and uncertainties, known and unknown, many of which are beyond DiagnoCure's control. As a result, investors are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements regarding the outcome of research and development projects, clinical studies and future revenues are based on management expectations. In addition, the reader is referred to the applicable general risks and uncertainties described in DiagnoCure's most recent Annual Information Form under the heading "Risk Factors". DiagnoCure undertakes no obligation to publicly update or revise any forward-looking statements contained herein.


'/>"/>
SOURCE DIAGNOCURE INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. DiagnoCure to webcast presentation at the Piper Jaffray Health Care Conference on December 3, 2008
2. DiagnoCure to present at the JMP Securities Healthcare Focus Conference on October 6, 2008
3. Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test
4. DiagnoCures GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group
5. DiagnoCure announces second quarter 2008 results
6. DiagnoCure to host Q2 2008 earnings conference call and webcast
7. DiagnoCures molecular diagnostic tests - PCA3 and GCC - discussed at scientific meetings
8. Susan G. Komen for the Cure(R) Announces Recipients of 2008 Komen Brinker Award for Scientific Distinction
9. Universal Health Realty Income Trust Announces Marc D. Miller Appointed to Board of Trustees and Dividend Increase
10. OneMedPlace announces panels for "OneMedForum 2009: Disrupters and Drivers in Eight Areas of Medical Technology" -- CEOs and investors to meet in unique format of focused sessions
11. Integrated Healthcare Holdings, Inc. Announces New Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... 17 Reportlinker.com announces that a ... its catalogue: ,, http://www.reportlinker.com/p0169956/Top-Ten-Worlds-Leading-Animal-Health-Companies.html ... the animal health industry executives with strategically ... to the development and implementation of effective ... objectives include: ,, To establish ...
(Date:12/17/2009)... following feature is by Devon Herrick, PhD, Senior Fellow ... People often assume they have little control over how ... sickness cannot be scheduled, doctors prescribe treatments and employers ... Americans. However, there are many overlooked ways to trim ... need. ,, Cut your prescription costs: ...
(Date:12/17/2009)... -- The National Council on Disability (NCD) ... Marriott Houston, 5150 Westheimer, Houston, TX, beginning at 8:30 ... 11:00 a.m. on Thursday, January 21, 2010. This meeting ... it is vital to hear from communities around the ... people with disabilities. This meeting will provide another opportunity ...
(Date:12/17/2009)... Maureen Neitz, the husband-and-wife team whose pioneering research may ... vision disorders, as the inaugural recipients of the Jay ... is funded by a $1 million endowment established this ... ,75 and Susan K. Feigenbaum ,74, his wife. The ... , The Neitzes, both of whom are faculty members ...
(Date:12/17/2009)... lung infections , , THURSDAY, Dec. 17 (HealthDay News) -- ... swine flu virus, and researchers say they,ve found a ... severity of the illness appears to be a molecule ... fight off germs and disease. Researchers who analyzed levels ... hospitals last summer found the highest levels in the ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4Health News:Six Ways to Slash Your Health Costs 2Health News:Six Ways to Slash Your Health Costs 3Health News:Six Ways to Slash Your Health Costs 4Health News:National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities 2Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2
... by the Pharmaceutical Research and Manufacturers of America (PhRMA) ... two of the three leading causes of death of ... are currently in clinical trials or under review by ... disease and stroke are still leading causes of death ...
... announces the launch of Global Health TV, a new ... and civil society on the major health issues faced ... is a collaborative project between HBL Media, a London-based ... Health TV website, http: www.globalhealthtv.com, will bring viewers three ...
... With the advent of a possible new blockbuster drug ... alcohol, and drug addictions, global sales of smoking cessation ... revenues of little over $1.1 billion in 2005 to ... Cessation and Addiction Treatments: A World Market Analysis, a ...
... inventor of Pulse CO-Oximetry and Read-Through Motion and Low ... presented at the Pediatric Academic Societies' (PAS) ... that switching to Masimo SET pulse oximetry technology can ... infants developing retinopathy of prematurity (ROP) by 40%.(1) One ...
... risk factors beyond those expected from weight loss in ... due to the drug itself, reports an article in ... ,Advertisements for rimonabant (sold under the ... 50% of the effects on cardiometabolic risk factors ...
... Medarex, Inc. today announced a collaborative research agreement ... Chemical Holdings Corporation . The two companies expect ... against a Mitsubishi target for the potential treatment ... Medarex's UltiMAb Human Antibody Development System(R) to generate ...
Other Medicine News:Health News:More Than 270 Medicines in Testing for Heart Disease and Stroke 2Health News:Masimo SET Pulse Oximetry Technology Significantly Reduce the Risk of ROP 2Health News:Masimo SET Pulse Oximetry Technology Significantly Reduce the Risk of ROP 3Health News:Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned 2
(Date:12/16/2009)... Accuray Incorporated (Nasdaq: ARAY ), a ... that its president and chief executive officer, Euan S. ... Annual J.P. Morgan Healthcare Conference in San Francisco on ... ET. ,, A live webcast of each presentation ... of the Company,s Web site at http://www.accuray.com . ...
(Date:12/16/2009)... A new application developed by American Imaging Management® ... pharmaceuticals has increased health plan staff productivity and ... ,, AIM, a leading diagnostic imaging benefit management ... over 35 million consumers and an operating subsidiary ... adapted the successful clinical and technology platform used ...
(Date:12/16/2009)... REYKJAVIK, Iceland, December 16 Scientists at,deCODE ... journal Nature the,discovery of a version of a ... genome (SNP) with a major impact on susceptibility ... T2D variant is not only large, but unusual:,if ... variant increases risk of,T2D by more than 30% ...
Breaking Medicine Technology:Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4GARP makes the difference 8832 1GARP makes the difference 8832 2Duke Harvard researchers to monitor bonobo reintroduction 8829 1Duke Harvard researchers to monitor bonobo reintroduction 8829 2Scientific evidence of health problems from past contamination of drinking water at Camp Lejeune is limited and unlikely to be resolved with further s 8826 1Scientific evidence of health problems from past contamination of drinking water at Camp Lejeune is limited and unlikely to be resolved with further s 8826 2Scientific evidence of health problems from past contamination of drinking water at Camp Lejeune is limited and unlikely to be resolved with further s 8826 3Scientific evidence of health problems from past contamination of drinking water at Camp Lejeune is limited and unlikely to be resolved with further s 8826 4
... NEW YORK, April 14 The Michael J. Fox,Foundation ... clinical trial,to investigate the potential of inosine -- a ... body -- to slow or stop the progression of,Parkinson,s ... Foundation,s LEAPS (Linked Efforts,to Accelerate Parkinson,s Solutions) 2007 initiative. ...
... Researchers at,the Barbara Ann Karmanos Cancer Institute ... to cancer patients. Today, at the American,Association ... researchers,Vitaly Balan, Ph.D., Pratima Nangia-Makker, Ph.D., and ... rs4644 Foretells Human Breast,Cancer Risk Associated with ...
Other Medicine Technology:Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine 2Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine 3Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women 2Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: